[1] SRIVASTAVA A, KAZE A D, MCMULLAN C J,et al. Uric acidand the risks ofkidneyfailure and death in individuals with CKD[J]. Am J Kidney Dis, 2018, 71(3):362-370. [2] 胡庆华,缪明星,卢国, 等. 槲皮素对尿酸性肾病大鼠肾脏NLRP3和TLRs表达的影响[J].中草药, 2013, 44(24):3496-3502. [3] ROMERO C A, REMOR A, LATINI A, et al. Uric acidactivates NRLP3 inflammasome in an in-vivo model of epithelial to mesenchymal transition in thekidney[J]. J Mol Histol, 2017, 48(3):209-218. [4] KIM H S, LIM S W, JIN L, et al. The protective effect offebuxostaton chronic tacrolimus-induced nephrotoxicity inrats[J]. Nephron, 2017, 135(1):61-71. [5] 罗来敏,陈钦开,杨小娟. 降尿酸治疗对痛风高尿酸血症患者IL-1β和NALP3水平的影响[J]. 南昌大学学报:医学版, 2016, 56(1):63-66. [6] MAZZALI M, HUGHES J, KIM Y G, et al. Elevateduricacidincreasesbloodpressurein theratby a novel crystal-independent mechanism[J]. Hypertension, 2001, 38(5):1101-1106. [7] 林章梅,张荣山,范晨雪, 等. 非布司他对高尿酸血症大鼠肾小管上皮间质转化及血清IL-6、转化生长因子β1的影响[J]. 中华内科杂志, 2017, 56(5):363-367. [8] CICERELLO E. Uric acidnephrolithiasis: an update[J]. Urologia, 2018, 85(3):93-98. [9] LI C C, CHIEN T M, WU W J, et al. Uric acidstones increase the risk of chronickidneydisease[J]. Urolithiasis, 2018, 46(6):543-547. [10] RAZI F, NASLI-ESFAHANI E, BANDARIAN F. Association of serumuric acidwithnephropathyin Iranian type 2 diabetic patients[J]. J Diabetes Metab Disord, 2018, 17(1):71-75. [11] YANG Q, FU C, XIAO J, et al. Uric acidupregulates the adiponectin adiponectin receptor1 pathway in renal proximal tubule epithelial cells[J]. Mol Med Rep, 2018, 17(3):3545-3554. [12] 王缘,白雪,王艳秋,等. NALP3在痛风炎症反应中的作用[J]. 黑龙江医药科学, 2015, 38(3):17-18,20. [13] HOSEINI Z, SEPAHVAND F, RASHIDI B, et al. NLRP3 inflammasome: its regulation and involvement in atherosclerosis[J]. J Cell Physiol, 2018, 233(3):2116-2132. [14] LÜTOLF R, HUGHES F M JR, INOUYE B M, et al. NLRP3/IL-1β mediates denervation during bladder outlet obstruction in rats[J]. Neurourol Urodyn, 2018, 37(3):952-959. [15] VAN LIESHOUT M H P, DE VOS A F, DESSING M C, et al. ASC and NLRP3 impair host defense during lethal pneumonia caused by serotype 3Streptococcus pneumoniae in mice[J]. Eur J Immunol, 2018, 48(1):66-79. [16] 张燕子,隋晓露,许云鹏, 等. NLRP3炎症小体信号通路对痛风性肾病的影响[J]. 中华肾脏病杂志, 2018, 34(5):387-388. [17] ALSHAHAWEY M, SHAHIN S M, ELSAID T W, et al. Effect of febuxostat on the endothelial dysfunction in hemodialysis patients: a randomized, placebo-controlled, double-blinded study[J]. Am J Nephrol, 2017, 45(5):452-459. [18] SABÁN-RUIZ J, ALONSO-PACHO A, FABREGATE-FUENTE M, et al. Xanthine oxidase inhibitor febuxostat as a novel agent postulated to act against vascular inflammation[J]. Antiinflamm Antiallergy Agents Med Chem, 2013, 12(1):94-99. [19] NISHIZAWA T, TANIURA T, NOMURA S. Effects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricemia[J]. Blood Coagul Fibrinolysis, 2015, 26(8):887-892. [20] 林章梅,张彩香,梁艳玲,等. 非布司他对高尿酸血症大鼠血清白介素6和转化生长因子β1水平的影响[J]. 中国糖尿病杂志, 2017, 25(7):655-658. |